Compounded semaglutide exists to solve access problems, not to replicate Wegovy's clinical results
MYTH: GLP1 Medications Are Just Weight Loss Drugs
Risks of Microdosing GLP-1 Reduced Effectiveness Because outcomes in clinical studies increase with therapeutic dosing, very low doses may not provide meaningful metabolic benefit
In individuals with obesity without T2DM, SURMOUNT- 1 evaluated the safety and effectiveness of tirzepatide 5, 10, and 15 mg once weekly in comparison to a placebo when paired with a 500 kcal/day deficit diet and recommendations for 150 min of weekly exercise [118]
The remaining question, then, is whether Pendulums probiotics deliver enough bacteria per serving
This is what GLP-1 protocol management often looks like when workflows arent built into your Electronic Health Record (EHR)